Drug
Glycopyrronium Bromide 25ug
Glycopyrronium Bromide 25ug: highest development phase Phase 2, developed by Novartis. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Novartis
Trials
| Drug | Phase | Indication |
|---|---|---|
| Glycopyrronium bromide 25ug NCT05222529 | Phase 2 | Asthma |
Latest
No recent events.
Follow Glycopyrronium Bromide 25ug on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.